Last Price
79.81
Today's Change
-2.18 (2.65%)
Day's Change
79.55 - 82.78
Trading Volume
573,361
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Reza Zadno Ph.D. Dr. Reza Zadno Ph.D.
Full Time Employees: 626 626
IPO Date: 2021-09-15 2021-09-15
CIK: 0001588978 0001588978
ISIN: US74276L1052 US74276L1052
CUSIP: 74276L105 74276L105
Beta: 1.03 1.03
Last Dividend: 0.00 0.00
Dcf Diff: 0.00 0.00
Dcf: 0.00 0.00
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.